As of 2026-03-22, the Relative Valuation of Chemours Co (CC) is (38.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.70 USD, the upside of Chemours Co based on Relative Valuation is -317.2%.
The range of the Relative Valuation is (38.27) - (40.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 16.5x | 15.4x |
| Forward P/E multiples | 13.2x - 15.9x | 14.4x |
| Fair Price | (38.27) - (40.99) | (38.45) |
| Upside | -316.2% - -331.6% | -317.2% |
| Date | P/E |
| 2026-03-20 | -6.88 |
| 2026-03-19 | -7.36 |
| 2026-03-18 | -7.40 |
| 2026-03-17 | -7.38 |
| 2026-03-16 | -6.86 |
| 2026-03-13 | -6.83 |
| 2026-03-12 | -6.88 |
| 2026-03-11 | -6.96 |
| 2026-03-10 | -6.92 |
| 2026-03-09 | -6.77 |
| 2026-03-06 | -6.38 |
| 2026-03-05 | -6.51 |
| 2026-03-04 | -6.82 |
| 2026-03-03 | -6.52 |
| 2026-03-02 | -7.00 |
| 2026-02-27 | -7.09 |
| 2026-02-26 | -6.73 |
| 2026-02-25 | -7.01 |
| 2026-02-24 | -7.16 |
| 2026-02-23 | -7.01 |
| 2026-02-20 | -6.63 |
| 2026-02-19 | -7.94 |
| 2026-02-18 | -8.22 |
| 2026-02-17 | -8.04 |
| 2026-02-13 | -7.98 |
| 2026-02-12 | -7.94 |
| 2026-02-11 | -8.17 |
| 2026-02-10 | -7.49 |
| 2026-02-09 | -7.36 |
| 2026-02-06 | -7.12 |
| 2026-02-05 | -6.57 |
| 2026-02-04 | -6.98 |
| 2026-02-03 | -6.42 |
| 2026-02-02 | -6.06 |
| 2026-01-30 | -5.83 |
| 2026-01-29 | -5.93 |
| 2026-01-28 | -5.88 |
| 2026-01-27 | -6.08 |
| 2026-01-26 | -6.14 |
| 2026-01-23 | -6.12 |
| 2026-01-22 | -6.24 |
| 2026-01-21 | -6.30 |
| 2026-01-20 | -5.93 |
| 2026-01-16 | -6.07 |
| 2026-01-15 | -6.05 |
| 2026-01-14 | -5.82 |
| 2026-01-13 | -5.71 |
| 2026-01-12 | -5.72 |
| 2026-01-09 | -5.56 |
| 2026-01-08 | -5.39 |